Metagenomic Sequencing Market Research Report- Forecast to 2027

Metagenomic Sequencing Market Research Report: By Technology (Sequencing, Bioinformatics) Application (Infectious Disease Diagnosis, Environmental Remediation, Gut Microbe Characterization, Biotechnology, Biofuel, Ecology, Agriculture) & ndash; Forecast To 2027

ID: MRFR/LS/4149-HCR | February 2021 | Region: Global | 90 pages

Metagenomic Sequencing Market Scenario:


Metagenomics sequencing is also known as environmental or community genomics. It is termed as the genomic study wherein the DNA of the specified host microorganism is extracted and cloned directly from the microorganism. Genetic testing is an expensive affair. Moreover, the testing requires specific infrastructure and resources. Currently, the genetic testing market is majorly spread in North American and West European regions. There are huge opportunities for the service providers and companies to make the tests affordable and enter the untapped regions of the world with a great scope of expanding. The reducing costs of the tests may also encourage people to undergo genetic tests.


The rising awareness of genetic disorders drives the global metagenomic sequencing market among the population. The advanced technological platforms and improved genomic tools are the key factors driving the growth of the market during the forecast period.  


Furthermore, the factors such as the use of advanced bioinformatics tools, recovery of novel drugs, high throughput screening (HTS) methods, and the development of cost-effective technologies such as next-generation sequencing (NGS) are driving the market growth. Moreover, rising R&D activities to identify new antibiotics and enzymes, and improved bioinformatics offers some attractive opportunities to the key market players. Growing concerns regarding the standardization and accuracy of diagnostic testing, lack of skilled professionals, and lack of knowledge is likely to restrain the market growth over the forecast period.


The metagenomic sequencing market size is expected to grow at a CAGR of approximately 6.5% during the forecast period 2017-2023.


Research Methodology


 metagenomic sequencing Market


Sources: Annual reports, Press release, White paper, and Company presentation

Segmentation                                                                                                


The global metagenomic sequencing market is segmented on the basis of technology, application, and end-user.


On the basis of the technology, the market is segmented into sequencing, bioinformatics, and others


On the basis of the application, the market is segmented into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, ecology, agriculture, and others


On the basis of the end-user, the global metagenomic sequencing market is segmented into hospitals, research institutes, specialized clinics, and others.


Regional Analysis


The global metagenomic sequencing market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.


The Americas region dominates the global metagenomic sequencing market owing to the technological advancements in the next generation sequencing procedures along with its increasing applications. The companies are focused on introducing the procedures with innovative technology. The unique opportunity drives the metagenomic sequencing market, and the focused issues stress on the need for more research on metagenomic sequencing tests. 


The European market holds the second largest share of the global metagenomic sequencing market owing to the increasing investment by the hospital facilities and government for better healthcare, growing collaborations and partnerships, the low cost of sequencing, and rising adoption of NGS procedure by research laboratories are driving the growth of this market.


The Asia Pacific market is expected to witness the fastest growth due to increasing prevalence of genetic disorders throughout the globe, which will boost the growth of the metagenomic sequencing market. Affordable healthcare and research are also major factor for the growth of the Asia Pacific metagenomic sequencing market. Major players are focusing on this region and investing money to expand their network that is helping them to capture major piece of the market. The Asia Pacific is anticipated to be the fastest growing region and is anticipated to compete with the European market over the forecasted period.


The Middle East and Africa are also expected to show a healthy growth in the coming five years. There are some factors affecting the growth of the Middle East metagenomic sequencing, such as lack of knowledge of genetic diseases and disorders, weak healthcare and research infrastructure, traditional healthcare practices, limited availability of products and services, and cost of the tests etc.


Key Players



  • GATC Biotech AG (Germany)

  • Enterome Bioscience (France)

  • Illumina Inc. (U.S.)

  • Aperiomics, Inc. (U.S.)

  • The Mitre Corporation (U.S.)

  • F Hoffman-La Roche Ltd. (Switzerland)

  • SciGenom Labs Pvt. Ltd. (India)

  • Second Genome Therapeutics (U.S.)

  • Quest Diagnostics Incorporated (U.S.)

  • Freenome Inc. (U.S.)

  • GenapSys, Inc. (U.S.)

  • COSMOSID (U.S.)

  • Pacific Biosciences (U.S.)

  • Beijing Genomics Institute (China)

  • Biomatters Ltd. (New Zealand)

  • Thermo Fisher Scientific Inc. (U.S.)

  • Oxford Nanopore Technologies Inc. (UK)

  • CLC Bio (Qiagen) (Denmark)

  • Agilent Technologies Inc. (U.S.)

  • DNAStar Inc. (U.S.)

  • Macrogen Inc. (South Korea)

  • Helicos BioSciences (U.S.)

  • Knome Inc. (U.S.)


Intended Audience



  • Metagenomic Sequencing Test Kit Suppliers

  • Metagenomic Sequencing Test Kit Manufacturers

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Academic Medical Institutes and Universities


 


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


Metagenomics sequencing, also known as environmental or community genomics, is a genomic study wherein the DNA of the specified host microorganism is extracted and cloned directly from the microorganism.

The market is expected to exhibit a strong 6.5% CAGR over the forecast period from 2017 to 2023.

The increasing research into genetics is likely to be a major driver for the market.

The Americas region dominates the global metagenomics sequencing market

Leading players in the metagenomics sequencing market include GATC Biotech, Enterome Bioscience, and Aperiomics, among others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Metagenomic sequencing Market, by Technology

6.1 Introduction

6.2 Sequencing

6.2.1 Market Estimates & Forecast, 2020 – 2023

6.3 Bioinformatics

6.3.1 Market Estimates & Forecast, 2020 – 2023

6.4 Others

Chapter 7. Global Metagenomic sequencing Market, by Application

7.1 Introduction

7.2 Infectious disease diagnosis

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Environmental remediation

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Gut microbe characterization

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Biotechnology

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Biofuel

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Ecology

7.7.1 Market Estimates & Forecast, 2020-2027

7.8 Agriculture

7.8.1 Market Estimates & Forecast, 2020-2027

7.9 Others

Chapter 8. Global Metagenomic sequencing Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Ambulatory Surgical Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Specialized Clinics

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Others

Chapter. 9 Global Metagenomic sequencing Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 U.K

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 GATC Biotech AG

11.1.1 Company Overview

11.1.2 Application Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Enterome Bioscience

11.2.1 Company Overview

11.2.2 Application Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Illumina Inc.

11.3.1 Company Overview

11.3.2 Application Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Quest Diagnostics

11.4.1 Company Overview

11.4.2 Applications/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 F Hoffman-La Roche Ltd.

11.5.1 Company Overview

11.5.2 Application Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Thermo Fisher Scientific Inc.

11.6.1 Company Overview

11.6.2 Application Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 CLC Bio

11.7.1 Overview

11.7.2 Application Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Agilent Technologies Inc.

11.8.1 Company Overview

11.8.2 Applications/Business Segment Overview

11.8.3 Financial Overview

11.8.4 Key Development

11.8.5 SWOT Analysis

11.9 Macrogen Inc.

11.9.1 Company Overview

11.9.2 Application Overview

11.9.3 Financial overview

11.9.4 Key Developments

11.10 Helicos BioSciences

11.10.1 Company Overview

11.10.2 Application Overview

11.10.3 Financial overview

11.10.4 Key Developments

11.11 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical industry

Chapter 13 Appendix

LIST OF TABLES

Table 1 Metagenomic sequencing Industry Synopsis, 2020-2027

Table 2 Metagenomic sequencing Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Metagenomic sequencing Market by Region, 2020-2027, (USD Million)

Table 4 Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 5 Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 6 Metagenomic sequencing Market by End Users, 2020-2027, (USD Million)

Table 7 North America Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 8 North America Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 9 North America Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 10 US Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 11 US Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 12 US Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 13 Canada Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 14 Canada Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 15 Canada Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 16 South America Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 17 South America Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 18 South America Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 19 Europe Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 20 Europe Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 21 Europe Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 22 Western Europe Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 23 Western Europe Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 24 Western Europe Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 25 Eastern Europe Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 26 Eastern Europe Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 27 Eastern Europe Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 28 Asia Pacific Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 29 Asia Pacific Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 30 Asia Pacific Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

Table 31 The Middle East & Africa Metagenomic sequencing Market by Technology, 2020-2027, (USD Million)

Table 32 The Middle East & Africa Metagenomic sequencing Market by Applications, 2020-2027, (USD Million)

Table 33 The Middle East & Africa Metagenomic sequencing Market by End User, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Metagenomic sequencing Market

Figure 3 Segmentation Market Dynamics for Metagenomic sequencing Market

Figure 4 Global Metagenomic sequencing Market Share, by Technology 2020

Figure 5 Global Metagenomic sequencing Market Share, by Application2020

Figure 6 Global Metagenomic sequencing Market Share, by End Users, 2020

Figure 7 Global Metagenomic sequencing Market Share, by Region, 2020

Figure 8 North America Metagenomic sequencing Market Share, by Country, 2020

Figure 9 Europe Metagenomic sequencing Market Share, by Country, 2020

Figure 10 Asia Pacific Metagenomic sequencing Market Share, by Country, 2020

Figure 11 The Middle East & Africa Metagenomic sequencing Market Share, by Country, 2020

Figure 12 Global Metagenomic sequencing Market: Company Share Analysis, 2020 (%)

Figure 13 GATC Biotech AG: Key Financials

Figure 14 GATC Biotech AG: Segmental Revenue

Figure 15 GATC Biotech AG: Geographical Revenue

Figure 16 Enterome Bioscience: Key Financials

Figure 17 Enterome Bioscience: Segmental Revenue

Figure 18 Enterome Bioscience: Geographical Revenue

Figure 19 Illumina Inc.: Key Financials

Figure 20 Illumina Inc.: Segmental Revenue

Figure 22 Illumina Inc.: Geographical Revenue

Figure 23 Quest Diagnostics: Key Financials

Figure 24 Quest Diagnostics: Segmental Revenue

Figure 25 Quest Diagnostics: Geographical Revenue

Figure 27 F Hoffman-La Roche Ltd.: Key Financials

Figure 28 F Hoffman-La Roche Ltd.: Segmental Revenue

Figure 29 F Hoffman-La Roche Ltd.: Geographical Revenue

Figure 30 Thermo Fisher Scientific Inc.: Key Financials

Figure 32 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 33 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 33 Tornier N.V.: Key Financials

Figure 34 Tornier N.V.: Segmental Revenue

Figure 35 Tornier N.V.: Geographical Revenue

Figure 36 Össur: Key Financials

Figure 37 Össur: Segmental Revenue

Figure 38 Össur: Geographical Revenue

Figure 39 Acumed, LLC: Key Financials

Figure 40 Acumed, LLC: Segmental Revenue

Figure 41 Acumed, LLC: Geographical Revenue